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Abstract
Background and aims: Patient-reported outcome measures (PROMs) make it possible to assess
health-status problems from the perspective of persons suffering from a disease. The objective
of the paper is to examine and compare the contents of PROMs related to IBD based on the World
Health Organization's International Classification of Functioning, Disability and Health (ICF) as
the frame of reference.
Methods: A systematic literature review (1999–2009) in the databases Medline, EMBASE,
PsycINFO, CINAHL and CENTRAL was performed to select IBD-specific PROMs. Abstracts and
full-text articles were checked applying predefined eligibility criteria; IBD-specific PROMslobal Quality of Life; CENTRAL, Cochrane Central Register of Controlled Trials; CINAHL, Cumulative
rature; EMBASE, Excerpta Medica Database; IBDQOL, Inflammatory Bowel Disease Quality of Life Ques-
, Inflammatory Bowel Disease Questionnaire; ICF, International Classification of Functioning, Disability
re Analysis and Retrieval System Online; PROM, Patient-reported outcome measure; RFIPC, Rating Form
Inflammatory Bowel Disease Questionnaire; WPAI: CD, Work Productivity and Activity Impairment:
nt of Medical Informatics, Biometry and Epidemiology (IBE), Chair for Public Health and Health Services
ity (LMU), Marchioninistr. 17, 81377 Munich, Germany.
.lmu.de (A. Cieza).
f this publication lies with the ICF Research Branch.
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508 U. Achleitner et al.were identified. The contents of the identified PROMs were examined by linking the items to
ICF categories. The linked ICF categories of the PROMs were then compared.
Results: The review resulted in the selection of eight IBD-specific PROMs (e.g., Cleveland Global
Quality of Life, Inflammatory Bowel Disease Quality of Life Questionnaire, Inflammatory Bowel
Disease Questionnaire-32, Rating Form of IBD Patient Concerns, Short Inflammatory Bowel Dis-
ease Questionnaire). In total, 129 items were identified, the majority of which (n=90; 69.8%)
could be linked to specific ICF categories. None of the linked categories were contained in all
PROMs. The most frequently identified categories were ‘b1300 Energy level’, ‘b5254 Flatulence’,
‘d910 Community life’ and ‘d920 Recreation and leisure’.
Conclusion: The present study provides an overview of IBD-specific PROMs and their items. The re-
sults of the content comparison provide valuable information to facilitate and account for the selec-
tion of appropriate PROMs for different purposes of data collection in clinical and research settings.
© 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.Contents
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Inflammatory Bowel Disease (IBD) is a chronic disabling dis-
ease of the gastrointestinal tract.1,2 The most common enti-
ties are Crohn's disease (CD) and ulcerative colitis (UC) with
symptoms like diarrhea, rectal urgency, abdominal discom-
fort and weakness.3,4 Symptoms may not be limited to the
intestine but can also have extraintestinal manifestations af-
fecting e.g. the skin, joints and eyes.5 The disease is strongly
associated with limited performance of everyday activities
and restrictions in work and employment, recreation and re-
lationships with others,6,7 as well as reduced quality of
life.8-10 Thus, suffering from IBD includes not only impair-
ment of body functions and structures but also limitations
in activities of everyday life and restrictions in participation.
Consequentially, a comprehensive approach to functioning
and disability is required when addressing the impact of IBD.
A large number of outcome measures assess health-status
problems of persons with CD or UC.11 Many of these mea-
sures used in clinical practice or research are classification
or scoring systems that refer to disease activity and symp-
tomatology in IBD in terms of impaired body functions and
structures (e.g., Crohn's Disease Activity Index (CDAI),12 Har-
vey Bradshaw Index).13 Hence, disability and functioning
from a comprehensive point of view are poorly addressed
in these measures and do not cover the whole spectrum of
problems persons with IBD have to deal with.14,15Patient-reported outcome measures (PROMs) provide the
possibility to assess health-status problems from the per-
spective of persons suffering from a disease. The number
of IBD-specific PROMs which focus on aspects of functioning,
disability and health (e.g., Inflammatory Bowel Disease
Questionnaire (IBDQ-32)16, Rating Form of IBD Patient Con-
cerns (RFIPC)17, Inflammatory Bowel Disease Stress Index
(IBDSI)18) has increased over the last years so that the selec-
tion of the appropriate PROMs for specific purposes or sub-
populations has become a challenge. However, up to now
it has remained unclear whether these PROMs cover the
whole spectrum of functioning and disability.
The International Classification of Functioning, Disability
and Health (ICF) endorsed by the World Health Assembly as
a common language of functioning and disability19 is a prov-
en and useful tool for the examination and comparison of the
content of outcome measures.20–22 In 2010, Reichel et al.
published a paper on the linking of Crohn's disease health-
status measurements to the ICF.15 To our knowledge, no
overview has been published so far that examines the con-
tent of IBD-specific PROMs using the ICF as a reference.
Such an overview would facilitate the selection of PROMs
by clinicians and researchers.
The objective of this paper is, therefore, to examine the
content of IBD-specific PROMs using the ICF as a reference.
The specific aims are to identify (1) IBD-specific PROMs ap-
plied in studies of persons with IBD based on a systematic
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2009 and (2) which areas of functioning and disability have
been addressed by these PROMs using the ICF as a reference.
2. Materials and methods
A systematic literature review was performed to identify
IBD-specific PROMs used in studies of persons with IBD. In
our study, PROMs were defined as outcome measures in
which patients respond to a number of standardized ques-
tions asked in a paper-pencil form. The items of the identi-
fied PROMs were translated (“linked”) to the ICF. The
linked ICF categories provided the basis of the descriptive
analysis and the comparison of the content of the different
PROMs presented in this paper.
2.1. Step 1: systematic literature review: selection
of studies
Searches were performed in the literature databases Med-
line®, EMBASE, PsycINFO, CINAHL and CENTRAL by MC
using the search terms ‘Colitis, Ulcerative’, ‘Crohn Disease’,
‘Inflammatory Bowel Disease’ in MESH terms (if available),
title and abstract. Searches were limited to English articles
published between 1999 and 2009.
A random sample of about 25% of the abstracts identified
in the searches were screened and selected based on the fol-
lowing eligibility criteria: (1) human population, (2) sample
size more than 10 study participants, (3) age of at least
18 years, (4) main diagnoses of Crohn's disease (regional en-
teritis), Crohn's disease of small intestine, Crohn's disease of
large intestine, other Crohn's disease, ulcerative colitis, ul-
cerative (chronic) enterocolitis, ulcerative (chronic) ileoco-
litis, ulcerative (chronic) proctitis, ulcerative (chronic)
rectosigmoiditis, other ulcerative colitis and ulcerative coli-
tis, unspecified and (5) application of IBD-specific PROMs.
Studies should present first-hand data concerning persons
with IBD irrespective of the type of intervention or setting.
In addition, the information in the abstracts was used to as-
sure the inclusion of randomized controlled trials, clinical
controlled trials, cross-sectional studies, and longitudinal
observational studies. Reviews or meta-analyses, case re-
ports/case series, primary prevention studies, ecologic stud-
ies, economic evaluation studies and decision analyses were
excluded. Comments, letters, editorials, guidelines, confer-
ence reports, book chapters and dissertations were excluded
as well. Screening of abstracts was independently performed
by UA and NS. Consensus between the two researchers was
achieved to decide which abstracts to include. In case of dis-
agreement, pros and cons were discussed and if necessary a
third researcher (MC) was involved to reach consensus and to
decide on the inclusion of abstracts.
Full-text articles of the selected studies were retrieved
and checked applying the same eligibility criteria as reported
above.
2.2. Step 2: extraction of the selected studies
The IBD-specific PROMs reported in the selected studies, as
well as study-related characteristics specified in the methodsand results section (i.e. sample size, age and gender of study
participants, main diagnosis, type of intervention), were
extracted by UA and NS. Quality and plausibility checks of
the data extraction were performed by MC.
Data collected in steps 1 and 2 were documented in a
Microsoft® Access database. Descriptive statistics were
performed to describe the study-related characteristics of
the selected studies.
2.3. Step 3: linkage of the identified PROMs
In Step 3, the items in the identified questionnaires were
translated (“linked”) to the ICF. Based on its biopsychosocial
perspective, functioning encompasses the components Body
Functions, Body Structures and Activities and Participation.
Disability is an umbrella term for impairments in body func-
tions and body structures, as well as limitations in activities
and participation restrictions. The ICF also lists contextual
factors, namely Environmental Factors and Personal Factors
that interact with all these components. The entire classifi-
cation contains 1424 ICF categories each allotted to the
named components with the exception of Personal Factors,
which has not yet been classified. Each ICF category is denoted
by a code composed of a letter that refers to the components
of the classification (b: Body Functions; s: Body Structures;
d: Activities and Participation and e: Environmental Factors)
and is followed by a numeric code starting with the chapter
number (one digit), followed by the second level (two digits)
and the third and fourth levels (one digit each) of the classifi-
cation (see Fig. 1).
The linkage procedure started with the identification of
linking units contained in the items of the PROMs. These
linking units were then linked to the most specific ICF cate-
gory according to established linking rules by two indepen-
dent health professionals.23,24 Those linking units which
were not sufficient to make a decision about the most pre-
cise ICF category were assigned ‘nd’ (not definable). If a
linking unit was a personal factor as defined in the ICF, it
was assigned ‘pf’. If a linking unit was not represented by
the ICF, the code ‘nc’ (not covered) was chosen.
Consensus between the two independent researchers was
achieved to decide which ICF category was to be linked to
each linking unit. In case of disagreement, the arguments
were discussed and if necessary a third researcher (MC)
was involved to reach consensus and to decide on the final
category.
Kappa statistics with bootstrapped 95 percent confidence
intervals (95% CI) were calculated using SAS for Windows V
9.1 (SAS Institute Inc., Cary, NC, USA) to analyse the agree-
ment between the two health professionals who performed
the linking.25,26 The values of the Kappa coefficient general-
ly range from 0 to 1, whereas 1 indicates perfect agreement
and 0 indicates no additional agreement beyond what is
expected by chance alone.
2.4. Step 4: content comparison of the linked items
Absolute frequencies of the linked ICF categories addressed
in the items of the identified PROMs were calculated using
the second level of the ICF classification. Therefore, for
items linked to a third- or fourth-level ICF category the
Health condition
(disorder or disease)
ActivitiesBody Functions and Structures Participation
Environmental
Factors
Personal
Factors
b2 Sensory functions and pain   (ICF chapter)
b280 Sensation of pain (2nd-level ICF category)
b2801 Pain in body part (3rd-level ICF category)
b28012 Pain in stomach or abdomen  (4th-level ICF category)
Figure 1 The biopsychosocial perspective of the International Classification of Functioning, Disability and Health and its hierarchi-
cal structure.
510 U. Achleitner et al.respective second-level category was considered for analy-
sis. Since the ICF is organized in a hierarchical scheme,
more specific third- or fourth-level categories share the at-
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3.1. Systematic literature review: selection of studies
A total of 9728 papers were identified by the searches in the
five electronic databases. The randomly selected abstracts
of 2579 papers were checked on inclusion and exclusion
criteria according to the defined eligibility criteria. Based
on this abstract check, 221 studies were identified for further
analysis. Screening these 221 full-text articles, 46 studies
reporting the use of IBD-specific PROMs were finally selected.
The main reason for excluding full-text articles was the use of
non-IBD-specific PROMs.3.2. Extraction of the selected studies
Most of the selected studies were pharmaceutical interven-
tion studies (n=19, 41.3%) followed by nine longitudinal de-
scriptive studies (19.6%) and six cross-sectional descriptive
studies (13.0%). Two retrospective chart review studies
(4.3%) were included, as well as three undefined interven-
tion studies (6.5%), two surgical intervention studies (4.3%)
and five psychometric/diagnostic evaluation studies (10.9%).
Nearly half of the identified studies (n=19, 41.3%) in-
cluded persons with the main diagnosis CD. The main diag-
nosis in 16 studies (34.8%) was UC. Eleven studies (23.9%)
included both diagnoses.
There was a total sample size of 9396 persons ranging
from 12 to 1156 patients in the different individual studies.
The total sample included 3537 females (37.6%, missing
data n=5 studies). The mean age of the total sample was
39.5 years (SD=4.3, 18–79 years; data available in 27 stud-
ies). Table 1 shows the countries of origin of the included
studies.
The following eight IBD-specific PROMs were identified
in the retrieved studies: Cleveland Global Quality of Life
(Faszio Score) (CGQL)27, Inflammatory Bowel Disease Qual-
ity of Life Questionnaire (IBDQOL)28, IBDQ-3216, IBDSI18,
Inflammatory Bowel Disease Questionnaire — short form
(IBDQ-9)29,30, RFIPC17, Short Inflammatory Bowel Disease
Questionnaire (SIBDQ)31 and Work Productivity and Activi-
ty Impairment: Crohn's Disease (WPAI: CD)32. These
PROMs, their major characteristics and the number of the
studies which reported their use are shown in Table 2.Table 1 Countries of origin of the identified studies (N=46).
Country of origin n %
United States of America 11 23.9
Germany 7 15.2
Spain 6 13.0
United Kingdom 4 8.7
Sweden 4 8.7
Canada 2 4.3
Netherlands 2 4.3
Norway 2 4.3
Other countries 8 17.43.3. Linkage of the identified PROMs
In total, the eight IBD-specific PROMs included 129 items.
Ninety of them (69.8%) were linked to 45 specific ICF cate-
gories: 23 Body Functions' categories (51.1%), 1 Body Struc-
tures' category (2.2%), 13 categories of the component
Activities and Participation (28.9%) and 8 Environmental
Factors' categories (17.8%). Twenty-eight items (21.7%)
were linked to Personal Factors (pf) and 11 items to ‘nd’
and ‘nc’ (8.5%), respectively.
The Kappa statistic for the linking of the items was 0.61
[95% CI: 0.53–0.66].
3.4. Content comparison of the identified PROMs
The identified PROMs used to measure the disease impact on
patients' lives were linked to the common language of the
ICF. In detail, the IBDQ-32 covers the highest (n=24) and
the CGQL the lowest number of ICF categories (n=1). The
most Body Functions' categories were found in the IBDQ-32
(n=14) followed by the IBDQOL (n=12). The following
PROMs address the most categories of the component Activ-
ities and Participation: IBDQOL (n=7), IBDQ-32 (n=6) and
IBDSI (n=6).
Tables 3 to 5 show the coverage of ICF categories from
the components Body Functions, Body Structures, Activities
and Participation and Environmental Factors by the identi-
fied PROMs. None of the linked ICF categories are contained
in all PROMs. The most frequently identified categories are
‘b1300 Energy level’, ‘b5254 Flatulence’ (IBDQOL, IBDQ-32,
IBDQ-9, RFIPC and SIBDQ) and ‘d920 Recreation and leisure’
(IBDQOL, IBDQ-32, IBDSI, IBS-QOL and SIBDQ).
4. Discussion
The present study provides an overview and comparison of
IBD-specific PROMs with respect to their contents covered
using the ICF as a reference. The examination of the PROMs'
contents covered on the smallest possible units, namely, the
items of the questionnaires. This provided a clear and precise
picture of the addressed PROMs contents identified in this
study and enabled direct comparisons to be made. The results
of the content comparison provide valuable information to
facilitate and account for the selection of appropriate
IBD-specific PROMs for different purposes of data collection
in clinical and research settings.
Clinicians and researchers who define the aspects they
want to measure in terms of the ICF can directly use Tables 3
to 5 to look up which of the examined PROMs cover those
aspects. For example, a researcher dealing with the ques-
tion how IBD affects the sleep function of persons with IBD
will find the ICF category ‘b1342 Maintenance of sleep’ in
Table 3. In this table the researcher can see that the
items of the IBDQOL and the IBDQ-32 address this area
of functioning and might, therefore, present an adequate
choice in this context. Thus, PROMs and their items can
be easily matched to each other by using the ICF, thereby
simplifying the selection of PROMs.
Overall, the areas of functioning addressed in the items
of the identified PROMs are very diverse. There are just 4
ICF categories out of the 45 ICF categories linked to the 90
Table 2 Characteristics and frequencies of the identified IBD-specific PROMs in the included studies (N=46).
PROMs Frequency
n (%) a
Aim Mode of
administration
Number of
items
Response
options
Time
frame
Languages
CGQL Cleveland Global
Quality of Life
(Faszio Score)27
1 (1.7) Quality of life
after pelvicpouch
surgery
Self,
Interviewer
3 Rating 0–10 Today b English
IBDQOL Inflammatory
Bowel Disease
Quality of Life
Questionnaire28
6 (10.0) Quality of life Self 36 7-point
responses
Last
two
weeks
Multiple c
IBDQ-32 Inflammatory
Bowel Disease
Questionnaire16
36 (60.6) Quality of life Self,
Interviewer
32 7-point Likert
scale
Last
two
weeks
Multiple d
IBDQ-9 Inflammatory
Bowel Disease
Questionnaire —
short form29,30
1 (2.2) Quality of life Self,
Interviewer
9 Last
two
weeks
English
IBDSI Inflammatory
Bowel Disease
Stress Index18
2 (4.3) Overall life
satisfaction,
worries about
health,
relationships,
school, recreation,
sexuality,
body image,
psychosomatic
symptomatology
Self,
Interviewer
8 0 (no impact)
– 3 (great deal
of impact)
Today English
RFIPC Rating Form of IBD
Patient Concerns17
5 (10.9) Worries and
concerns
associated with IBD
and its treatments
Self 25 Visual Analog
Scale
Today Multiple e
SIBDQ Short Inflammatory
Bowel Disease
Questionnaire33
5 (10.9) Quality of life Self,
Interviewer
10 7-point Likert
scale
Last
two
weeks
Multiple f
WPAI:CD Work Productivity
and Activity
Impairment:
Crohn's Disease34
1 (2.2) Work and activity
impairment
Self,
Interviewer,
Telephone
6 Rating 0–10,
Number of hours
Last
seven
days
Multiple g
a Percentage of studies in which IBD-specific PROMs were applied; more than one PROMs could be applied in one study.
b At least one year after surgery.
c Original language: English; translated to Danish, Dutch, Finnish, French, German, Hebrew, Italian, Norwegian, Slovak, Spanish, and
Swedish.
d Original language: English; translated to Arabic, Bengali, Bulgarian, Chinese, Czech, Danish, Dutch, Finnish, French, German, Greek,
Gujarati, Hebrew, Hungarian, Italian, Japanese, Latvian, Lithuanian, Malayalam, Marathi, Norwegian, Polish, Portuguese, Punjabi,
Romanian, Russian, Serbian, Sesotho, Slovakian, Spanish, Swedish, Tamil, Telugu, Ukrainian, Urdu for India, Xhosa, and Zulu.
e Original language: English; translated to French, German, Hebrew, Italian, Portuguese, Spanish, and Swedish.
f Original language: English; translated to Arabic, Bengali, Bulgarian, Chinese, Czech, Danish, Dutch, Finnish, French, German, Greek,
Gujarati, Hebrew, Hungarian, Italian, Japanese, Latvian, Lithuanian, Malayalam, Marathi, Norwegian, Polish, Portuguese, Punjabi,
Romanian, Russian, Serbian, Sesotho, Slovakian, Spanish, Swedish, Tamil, Telugu, Ukrainian, Urdu for India, Xhosa, and Zulu.
g Original language: English; translated to Czech, Danish, Dutch, Finnish, French, German Greek, Hungarian, Icelandic, Italian, Japanese,
Norwegian, Polish, Portuguese, Slovak, Slovene, Spanish, and Swedish.
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This indicates that the individual PROMs and their items
differ widely in content. Examination of the PROMs' contents
remarkably shows that a high percentage of the linked ICF
categories applies to only two of the eight selected PROMs,
namely IBDQOL and IBDQ-32. This means that many topics
are addressed in these two PROMs, and no other PROMs include
them.An important finding of this study refers to the represen-
tation of pain in IBD. Only three PROMs (IBDQ-32, RFIPC,
SIBDQ) include items addressing sensory functions and pain,
even if in clinical practice pain is stated in the case history
of many persons diagnosed with IBD.33,34 Bielefeldt et al.
showed that not only inflammation, but also bowel obstruc-
tions, can manifest as pain, and even a subgroup of IBD pa-
tients without evidence of overt inflammation, obstruction
Table 3 ICF categories of the components Body Functions and Body Structures addressed in IBD-specific PROMs.
ICF categories PROMs
ICF
code
ICF title CGQL IBDQOL IBDSI IBDQ-
32
IBDQ-
9
RFIPC SIBDQ WPAI:
CD
b Body functions
b1 Mental functions
b130 Energy and drive functions + +
b1300 Energy level + + + + +
b1302 Appetite +
b1308 Energy and drive functions, other specified + +
b1341 Onset of sleep +
b1342 Maintenance of sleep + +
b1343 Quality of sleep +
b152 Emotional functions + + +
b1801 Body image +
b2 Sensory functions and pain
b280 Sensation of pain +
b2801 Pain in body part + +
b28012 Pain in stomach or abdomen + +
b5 Functions of the digestive, metabolic and endocrine
systems
b5150 Transport of food through stomach and intestines + + +
b525 Defecation functions + + + +
b5253 Faecal continence +
b5254 Flatulence + + + + +
b530 Weight maintenance functions + + +
b535 Sensations associated with the digestive system + +
b5350 Sensation of nausea +
b5351 Feeling bloated + +
b5352 Sensation of abdominal cramp + + +
b6 Genitourinary and reproductive functions
b640 Sexual functions +
b660 Procreation functions +
s Body structures
s5 Structures related to the digestive, metabolic and
endocrine systems
s540 Structures of intestine + +
CGQL Cleveland Global Quality of Life (Faszio Score); IBDQOL Inflammatory Bowel Disease Quality of Life Questionnaire; IBDSI IBD Stress
Index; IBDQ-32 Inflammatory Bowel Disease Questionnaire; IBDQ-9 Inflammatory Bowel Disease Questionnaire short form; RFIPC Rating
Form of IBD Patient Concerns; SIBDQ Short Inflammatory Bowel Disease Questionnaire; WPAI:CD Work Productivity and Activity Impair-
ment: Crohn's Disease.
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pain. Thus, pain or fear of pain constitute a significant burden
for persons with IBD and can reduce their quality of life.35,36
One of the most frequently covered ICF categories is
'b1300 Energy level'. Rooy et al. point out that the level of
energy is the most intense concern of persons with IBD if
the RFIPC is used as a PROM for examination.34
In three PROMs ‘b152 Emotional functions’, which in-
cludes feelings like sadness, happiness, anxiety or sorrow,
is covered (IBDQOL, IBDQ-32, SIBDQ). Whereas ‘b1801 body
image’, which includes the feeling of being too fat or too
thin is poorly, represented in only one PROM (IBDSI). Muller
et al. show that the majority of persons with IBD report
that the disease affects their body image; particularly fe-
males who have had abdominal surgery describe a negative
impact on their body image.37
The question about maintenance of sleep or the quality of
sleep is addressed in only two PROMs. Considering the factpersons with IBD complained of repeated awakening at night
twice as often as healthy controls38 this area of functioning
is poorly represented in the identified PROMs. A healthy
sleep–wake cycle is critical for the regulation of immune and
neuroendocrine functions39, and sleepiness and fatigue are
often the cardinal manifestations of acute inflammatory
disorders.36 For persons with IBD, repeated awakenings
are, among other reasons, attributed to the need to use
the bathroom. A further important finding of this study
was that none of the identified PROMs and their items
covered the category ‘d530 Toileting’ which refers to
ordinating and managing defecation and getting to an ap-
propriate place for defecation. Stjernman et al. show
that persons with IBD are often concerned about their
loss of bowel control and are worried about finding a toilet
in time.40
It is interesting that only 13 categories of the component
Activities and Participation were linked to the items of the
Table 4 ICF categories of the component Activities and Participation addressed in IBD-specific PROMs.
ICF categories PROMs
ICF
code
ICF title CGQL IBDQOL IBDSI IBDQ-
32
IBDQ-
9
RFIPC SIBDQ WPAI:
CD
d Activities and Participation +
d2 General tasks and demands
d230 Carrying out daily routine +
d7 Interpersonal interactions and relationships +
d760 Family relationships +
d770 Intimate relationships + +
d7702 Sexual relationships + +
d8 Major life areas
d820 School education + + +
d850 Remunerative employment + + +
d859 Work and employment, other specified and
unspecified
+
d9 Community, social and civic life +
d910 Community life + + + +
d920 Recreation and leisure + + + +
d9201 Sports + + +
CGQL Cleveland Global Quality of Life (Faszio Score); IBDQOL Inflammatory Bowel Disease Quality of Life Questionnaire; IBDSI IBD Stress
Index; IBDQ-32 Inflammatory Bowel Disease Questionnaire; IBDQ-9 Inflammatory Bowel Disease Questionnaire short form; RFIPC Rating
Form of IBD Patient Concerns; SIBDQ Short Inflammatory Bowel Disease Questionnaire; WPAI:CD Work Productivity and Activity Impair-
ment: Crohn's Disease.
514 U. Achleitner et al.IBD-specific PROMs. In a qualitative study Peyrin-Biroulet
et al. show that various aspects of activities and participa-
tion (e.g. sexual relationships, managing diet and fitness,
remunerative employment) are important from the patient
perspective.41 These areas are poorly represented in IBD-
specific PROMs. However, some of the identified PROMsTable 5 ICF categories of the component Environmental Factors
ICF categories
ICF
code
ICF title
e Environmental factors
e1 Products and technology
e1101 Drugs
e1151 Assistive products and technology for personal use in dail
living
e1501 Design, construction and building products and technology
gaining access to facilities inside buildings for public use
e165 Assets
e4 Attitudes
e5 Services, Systems and policies
e580 Health services, systems and policies
e5800 Health services
pf Personal factors
nd Not definable
nd-hc Not definable: Health condition
nd-gh Not definable: General health
nd-QoL Not definable: Overall quality of life
nc Not covered
CGQL Cleveland Global Quality of Life (Faszio Score); IBDQOL Inflamm
Index; IBDQ-32 Inflammatory Bowel Disease Questionnaire; IBDQ-9 Infl
Form of IBD Patient Concerns; SIBDQ Short Inflammatory Bowel Diseas
ment: Crohn's Disease.and their items (IBDQOL, IBDQ-32, IBDSI) cover a few ICF
categories addressing activities of daily living and social
participation: interpersonal interactions, work or school
education or community, social and civic life.
It could be argued that the results of this investigation
suggest that the lack of coverage of important areas by theaddressed in IBD-specific PROMs.
PROMs
CGQL IBDQOL IBDSI IBDQ-
32
IBDQ-
9
RFIPC SIBDQ WPAI:
CD
+
+ +
y +
for + +
+
+
+
+
+ + + + + +
+ +
+
+ + + +
+
+
atory Bowel Disease Quality of Life Questionnaire; IBDSI IBD Stress
ammatory Bowel Disease Questionnaire short form; RFIPC Rating
e Questionnaire; WPAI:CD Work Productivity and Activity Impair-
515Identification of areas of functioning and disability addressed in IBD-specific PROMSIBD-specific PROMs could be compensated by the joint use of
IBD-specific and generic PROMs, such as the 36-Item Short
Form Survey (SF-36).42 However, a comparison of the results
of this study with the results of a previous one, in which the
similarities and differences in content of the most widely
used generic PROMs were studied, shows that these PROMs
are very heterogeneous and that, as is the case in the
condition-specific PROMs, they frequently do not cover
some important areas in IBD, such as toileting and sexuali-
ty.20 Toileting is only covered in the Spitzer's Quality of
Life Index (QL-I)43 and intimate relationships and sexuality
only in the WHO Quality of Life-BREF (WHOQOL-BREF)44,
World Health Organization Disability Assessment Schedule II
(WHODAS II)45 and Nottingham Health Profile (NHP)46. The
generic PROMs analyzed in the mentioned study show a
very high level of depth of coverage and granularity in mo-
bility, which is a less relevant area in IBD. This comparison
suggests that when selecting instruments for an investiga-
tion a very careful study of the contents of both the IBD-
specific and generic PROMs is necessary to ensure that all
relevant aspects of IBD and all study endpoints are covered
without imposing unnecessary burden on the patients. The
study of the psychometric properties is also important. For
example, McColl et al. recommend the use of both types
of PROMs in parallel based on the comparison of the dis-
criminatory power of the SF-36 and the IBDQ.47 While dis-
ease activity was more highly correlated with IBDQ scores
than with SF-36 scores, significant differences with respect
to disease severity were found in the SF-36's energy/fatigue
and social-function scales.
Last but not least, an ICF-based examination of the PROMs'
contents could facilitate the development of new or modi-
fied PROMs. Presenting an overview of the most- or least-
frequently mentioned ICF categories covering the items of
the identified PROMs this paper could be used to identify
areas of functioning and health. This information could
lead to the development of more specific PROMs for clinical
evaluation and research in IBD.
The current study has several limitations. The systematic
literature review used to identify IBD-specific PROMs was
based on a simplified review method using specific, rather
than sensitive, search strategies. For practicability reasons,
the number of abstracts to be checked was decreased by a
random selection. Moreover, we largely relied on informa-
tion contained in abstracts. We did not consider other
outcome measures reported in the full-text articles of
the retrieved studies (e.g. disease classifications or indi-
ces). However, in comparison to other reviews on PROMs
in IBD,11,48 the PROMs identified in this paper cover the
most frequently used and established PROMs in IBD.
In this study the contents of IBD-specific PROMs and
their items were examined to provide an overview of the
areas of functioning and disability addressed by these
PROMs using the ICF as a reference. This overview should
facilitate the selection of PROMs in clinical practice and
research. This paper does not claim to be complete in terms
of the frequencies of the identified PROMs. We tried to
introduce a new tool, the ICF, for content comparison
among IBD-specific PROMs and described its advantages
by means of the given analyses. The method still can be
explained without having analyzed all possibly available full-
text articles. Finally, the linking process was performed bytwo medical doctors trained in the ICF and the application of
the linking rules. However, it remains unclear whether other
health professionals would have decided differently.
In conclusion, the ICF provides a useful framework for
examining and comparing IBD-specific PROMs and their
items with respect to the areas of functioning and disability
covered. This information can be useful in selecting PROMs
for clinical practice, as well as for any kind of investigations
in which functioning and disability of persons with IBD is
a relevant study outcome. None of the PROMs identified
in this study are ideal for all applications. However, after
having decided on “what should be measured”, this paper
may well assist clinicians and researchers in deciding on
the most suitable PROM. The results of this study emphasize
the need for a comprehensive PROM covering the whole
spectrum of functioning and disability in IBD.Acknowledgements
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